Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

July 30, 2007

JSM 6427: the new face of armd therapy

Analysis of: FDA Accepts Jerini Ophthalmic's IND of JSM 6427 for the Treatment of AMD | www.pipelinereview.com
This analysis is solely the work of the author. It has not been edited or endorsed by GLG.
Analysis By:
Gaurav Shah, MD, Associate Professor of OphthalmologyGaurav Shah, MD
Associate Professor of Ophthalmology, Washington University Medical Center
Implications: 1.  A molecule that allows on to stop neovascular armd to form from dry armd 2.  A product with a potentially large  market share compared to the current agents available 3.  A compound that could have a sustained drug delivery module

Analysis:  this particular compound is exciting for the community since this compound prevents wet macular degernation from ever occuring from dry macular degneration.  Not only may this compond prevent vegf upgergulation but it also may be able to prevent fibrosis which is the  number casue of lost vision after currrent therapeutics option.  This compound may also be able to used as an extended delivery device which may make it very usefull for patients

Other Analyses of the Same Source Article:
The next wave of AMD drugs? It's too early to say...
July 19, 2007, Author: GLG Expert Contributor
New approach to AMD treatment
July 18, 2007, Author: GLG Expert Contributor
Anti-Integrins: A New Potential Treatment Modality for Wet (Neovascular) AMD?
July 17, 2007, Author: GLG Expert Contributor
A new safe and sustaining adjunct to the treatment of neovascular AMD
July 17, 2007, Author: GLG Expert Contributor

Report a Concern

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-02T05:45:17.627